Action A003060 APROGEN BIOLOGICS INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Aprogen Biologics Inc.

Actions

A003060

KR7003060001

Cours en clôture Korea S.E.
Autres places de cotation
 00:00:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
1 565 KRW -0,13 % Graphique intraday de Aprogen Biologics Inc. +5,03 % -46,03 %
13/03 Aprogen Biologics Inc. publie ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 Aprogen Biologics Inc. publie ses résultats pour le troisième trimestre et les neuf mois clos le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Aprogen Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Aprogen Biologics Inc.(KOSE:A003060) dropped from S&P Global BMI Index
Aprogen Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Aprogen Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Aprogen Biologics Inc. announced that it has received KRW 20 billion in funding from Aprogen, Inc.
Aprogen Biologics Inc. announced that it expects to receive KRW 20 billion in funding from Aprogen, Inc.
Aprogen Biologics Inc. announced that it has received KRW 40 billion in funding
Aprogen Biologics Inc. announced that it expects to receive KRW 40 billion in funding
Aprogen Biologics Inc. announced that it has received KRW 40.0000005 billion in funding from Aprogen Medicines Inc.
Aprogen pharmaceuticals,Inc. completed the acquisition of Aprogen Biologics Inc. from Aprogen, Inc.
Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Aprogen Pharmaceuticals to Raise $35.1 Million Through Stock Issuance
Aprogen pharmaceuticals,Inc. agreed to acquire Aprogen Biologics Inc. from Aprogen, Inc.
Aprogen Biologics Inc. announced that it expects to receive KRW 50 billion in funding from Aprogen Medicines Inc.
Aprogen pharmaceuticals,Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Aprogen pharmaceuticals,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Aprogen pharmaceuticals,Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Aprogen pharmaceuticals,Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Aprogen Medicines Inc. announced that it expects to receive KRW 105 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd., Aprogen pharmaceuticals,Inc., Aprogen Healthcare & Games Inc.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action A003060
  4. Actualités Aprogen Biologics Inc.
  5. Autres langues